German Medtechs Say MDR Ball Is In EU’s Court, Plus DRG Changes and ESG Reactions
Jury is out on planned market access changes affecting German and EU medtech industries
Marc-Pierre Möll, CEO of German medtech-industry association BVMed, is hoping for a more collaborative year in 2023 after the health ministry came out with proposals to change the DRGs system and the EU finally conceded that its unhelpful MDR timetable was riding roughshod over the wellbeing of patients.
